Unnamed: 0,title,date,stock,sentiment
921518.0,"NanoString, OnRamp Reports Partnership To Develop Cloud-Based Analysis Solutions For nCounter Data",2020-05-20 09:01:00-04:00,NSTG,positive
921519.0,"NanoString Technologies Q1 EPS $(1.040) May Not Compare To $(0.520) Estimate, Sales $24.500M Miss $25.420M Estimate",2020-05-07 16:13:00-04:00,NSTG,negative
921520.0,"UBS Maintains Buy on NanoString Technologies, Lowers Price Target to $38",2020-04-28 11:40:00-04:00,NSTG,negative
921521.0,NanoString Earlier Reported First Publication Utilizing nCounter Platform For Measuring Immune Response In Coronavirus Research,2020-04-15 09:41:00-04:00,NSTG,positive
921522.0,"Baird Maintains Outperform on NanoString Technologies, Lowers Price Target to $29",2020-04-07 08:54:00-04:00,NSTG,negative
921523.0,NanoString Withdraws FY20 Guidance,2020-04-06 16:03:00-04:00,NSTG,neutral
921524.0,NanoString Reports 15+ New GeoMx DSP Instrument Orders In Q1,2020-04-06 16:02:00-04:00,NSTG,neutral
921525.0,"NanoString Reports Its nCounter Instrument, Consumable Sales Have Been Disrupted By Coronavirus Pandemic",2020-04-06 16:02:00-04:00,NSTG,neutral
921526.0,"NanoString Reports GeoMx DSP Orders, Sales Inline With Prior Guidance",2020-04-06 16:01:00-04:00,NSTG,neutral
921527.0,"Stifel Maintains Buy on NanoString Technologies, Lowers Price Target to $35",2020-04-02 11:30:00-04:00,NSTG,negative
921528.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-27 10:24:00-05:00,NSTG,neutral
921529.0,NanoString Sees FY20 Sales $124M-$131M A Increase Of 20%-26% Up YoY,2020-02-26 16:02:00-05:00,NSTG,positive
921530.0,"NanoString Technologies Q4 EPS $(0.61) Misses $(0.58) Estimate, Sales $33.6M Miss $34.46M Estimate",2020-02-26 16:00:00-05:00,NSTG,negative
921531.0,NanoString Technologies Highlights Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology Conference,2020-02-20 06:14:00-05:00,NSTG,neutral
921532.0,Jounce Highlights Presentation Of New Vopratelimab Predictive Biomarker Data At ASCO-SITC Symposium,2020-02-06 08:09:00-05:00,NSTG,neutral
921533.0,NanoString Preliminary FY 2019 Revenue $103.7M vs $121.36M Est; Q4 Revenue $33.6M vs $34.02M Est,2020-01-12 19:12:00-05:00,NSTG,neutral
921534.0,"NanoString Announces Creation Of GeoMx Breast Cancer Consortium, Which Plans To 'Apply Spatial Analysis to Major Challenges in Breast Cancer Research'",2019-12-11 06:05:00-05:00,NSTG,negative
921535.0,"Nanostring Technologies Says on December 3, Co Entered Into a License & Asset Purchase Agreement With Veracyte; Co Granted to Veracyte Exclusive Worldwide License to Ncounter Flex Analysis System; Sold to Veracyte Certain Assets",2019-12-04 06:08:00-05:00,NSTG,positive
921536.0,Veracyte Acquires Exclusive License to NanoString Diagnostics Platform For $40M In Cash And $10M In Stock; Co. Sees $6M-$8M Revenue Contribution In 2020,2019-12-03 17:03:00-05:00,NSTG,positive
921537.0,"Benzinga's Top Upgrades, Downgrades For November 15, 2019",2019-11-15 09:59:00-05:00,NSTG,positive
921538.0,"Stifel Nicolaus Initiates Coverage On NanoString Technologies with Buy Rating, Announces $28 Price Target",2019-11-15 06:41:00-05:00,NSTG,neutral
921539.0,NanoString Technologies Sees FY19 Sales $121M-$124M vs $120.55M Est,2019-11-04 16:09:00-05:00,NSTG,neutral
921540.0,"NanoString Technologies Q3 EPS $(0.64) Misses $(0.54) Estimate, Sales $30.604M Beat $28.05M Estimate",2019-11-04 16:07:00-05:00,NSTG,negative
921541.0,NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling,2019-11-04 06:22:00-05:00,NSTG,negative
921542.0,"NanoString Announces Don Kania, Ph.D. To Its Board Of Directors.",2019-10-31 07:21:00-04:00,NSTG,neutral
921543.0,NanoString Technologies Earlier Announced Mark Winham As SVP Of Operations,2019-10-02 09:16:00-04:00,NSTG,neutral
921544.0,NanoString Introduces New Gene Expression Research Panel for Human Organ Transplantation,2019-09-23 06:03:00-04:00,NSTG,neutral
921545.0,Shares of several healthcare companies are trading lower on escalated trade tensions after China announced it plans to impose a 5% to 10% tariff rate on $75 billion worth of U.S. goods. Trump announced he will respond to China's tariffs this afternoon.,2019-08-23 12:40:00-04:00,NSTG,negative
921546.0,NanoString Technologies 13G From Morgan Stanley Shows 11.1% Stake,2019-08-12 16:25:00-04:00,NSTG,neutral
921547.0,NanoString Highlights Publication Demonstrating Co.'s GeoMx Digital Spatial Profiler,2019-08-06 06:26:00-04:00,NSTG,neutral
921548.0,100 Biggest Movers From Yesterday,2019-08-02 05:53:00-04:00,NSTG,neutral
921549.0,72 Stocks Moving In Thursday's Mid-Day Session,2019-08-01 12:16:00-04:00,NSTG,neutral
921550.0,Stocks That Broke Yearly Highs Thursday Morning,2019-08-01 10:19:00-04:00,NSTG,negative
921551.0,Stocks That Managed to Breach 52-Week Highs Wednesday Morning,2019-07-31 11:01:00-04:00,NSTG,neutral
921552.0,NanoString Technologies Reports Joint Development Deal With Mayo Clinic To Develop Novel Assays,2019-07-30 09:31:00-04:00,NSTG,positive
921553.0,NanoString Technologies Reports Publication Of Study In Journal Nature Medicine Showing Capability Of GeoMx Digital Spatial Profiler To Characterize Toxicities Associated With Immunotherapy Using Checkpoint Inhibitors,2019-07-22 16:04:00-04:00,NSTG,negative
921554.0,NanoString Technologies Highlights Publication Of GeoMx Digital Spatial Profiler In Nature MAgazine,2019-07-22 16:04:00-04:00,NSTG,neutral
921555.0,NanoString Partners With Multiple Leading Contract Research Organizations To Provide Standardized PanCancer IO 360 Data Analysis Reports,2019-05-30 16:01:00-04:00,NSTG,neutral
921556.0,NanoString Technologies Reiterates FY19 Revenues Of $118M-$123M Vs. $120.62M Estimate; Reiterates FY19 EPS Guidance Of $(2.30) To $(2.45) Vs. $(2.37) Estimate,2019-05-09 16:40:00-04:00,NSTG,neutral
921557.0,"NanoString Technologies Q1 EPS $(0.69) Misses $(0.6) Estimate, Sales $27.688M Beat $25.52M Estimate",2019-05-09 16:38:00-04:00,NSTG,negative
921558.0,"NanoString Reports Leica Biosystems To Co-Market GeoMx Digital Spatial Profiling, Leica's BOND RX Platforms For High Throughput Spatial Analysis",2019-04-02 09:19:00-04:00,NSTG,neutral
921559.0,"NanoString, Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler",2019-04-01 06:09:00-04:00,NSTG,neutral
921560.0,Bio-Techne And NanoString Partner To Co-Develop Integrated Workflow For RNA Spatial Profiling,2019-03-28 06:09:00-04:00,NSTG,neutral
921561.0,NanoString Reports Commercial Launch Of GeoMx Digital Spatial Profiler,2019-03-27 06:11:00-04:00,NSTG,neutral
921562.0,NanoString Technologies 8-K Shows Co. Terminated Sales Deal With Cowen For $40M Sale,2019-03-25 16:08:00-04:00,NSTG,neutral
921563.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-03-20 07:38:00-04:00,NSTG,neutral
921564.0,70 Biggest Movers From Yesterday,2019-03-20 05:36:00-04:00,NSTG,neutral
921565.0,NanoString Technologies 4.5M Share Offering of Common Stock $23.00/Share,2019-03-19 18:36:00-04:00,NSTG,positive
921566.0,NanoString Reports 4.5M Share Common Stock Offering,2019-03-18 16:21:00-04:00,NSTG,positive
921567.0,"NanoString Technologies Sees FY19 EPS $(2.45)-$2.30) vs $(2.02) Est., Sales $118M-$122M vs $122.74M Est.",2019-03-07 16:04:00-05:00,NSTG,neutral
921568.0,"NanoString Technologies Q4 EPS $(0.68) Misses $(0.49) Estimate, Sales $23.6M Miss $29.19M Estimate",2019-03-07 16:03:00-05:00,NSTG,negative
921569.0,"Earnings Scheduled For March 7, 2019",2019-03-07 04:01:00-05:00,NSTG,neutral
921570.0,"Stocks Which Set New 52-Week High Fri., Jan. 11, 2019",2019-01-14 09:47:00-05:00,NSTG,neutral
921571.0,56 Biggest Movers From Yesterday,2019-01-10 05:16:00-05:00,NSTG,neutral
921572.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Jan. 7, 2019",2019-01-08 11:04:00-05:00,NSTG,neutral
921573.0,NanoString Technologies Preliminary Q4 Revenue ~$23.8M; Above Upper End of Company's Guidance Range of $22M to $23M; FY Revenue ~$83.5M; Above Upper End of Company's Guidance Range of $82M to $83M,2019-01-07 04:12:00-05:00,NSTG,neutral
921574.0,NanoString Technologies Reports UK's National Institute For Health And Care Excellence Issued Recommendation Prosigna Assay Use Results To Guide Adjuvant Chemotherapy Decisions In Early-Stage Breast Cancer Patients,2018-12-19 16:07:00-05:00,NSTG,positive
921575.0,85 Biggest Movers From Friday,2018-11-12 05:16:00-05:00,NSTG,neutral
921576.0,68 Stocks Moving In Friday's Mid-Day Session,2018-11-09 12:42:00-05:00,NSTG,neutral
921577.0,Mid-Morning Market Update: Markets Open Lower; II-VI To Buy Finisar In $3.2B Deal,2018-11-09 10:26:00-05:00,NSTG,negative
921578.0,NanoString Technologies shares are trading higher after the company raised 2018 EPS guidance.,2018-11-09 10:20:00-05:00,NSTG,positive
921579.0,NanoString Technologies Raises FY2018 EPS Guidance from $(2.50)-(2.70) to $(2.50)-(2.60) vs $(2.54) Est; Maintains FY2018 Sales Guidance of $104.0M-106.0M vs $105.59M Est,2018-11-08 16:44:00-05:00,NSTG,neutral
921580.0,"NanoString Technologies Q3 EPS $(0.56) Beats $(0.57) Estimate, Sales $28.616M Beat $26.2M Estimate",2018-11-08 16:42:00-05:00,NSTG,neutral
921581.0,NanoString Highlights Advances In Product Pipeline And Application Development At The 2018 Association Of Molecular Pathology Conference Oct. 31-Nov. 1,2018-10-30 06:28:00-04:00,NSTG,neutral
921582.0,NanoString Technologies and MacroGenics Announce a Research Agreement to Identify Biomarkers for MacroGenic's MGD013,2018-10-29 06:11:00-04:00,NSTG,positive
921583.0,46 Biggest Movers From Yesterday,2018-10-10 05:08:00-04:00,NSTG,neutral
921584.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-10-09 12:39:00-04:00,NSTG,neutral
921585.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,NSTG,neutral
921586.0,"Stocks Which Set New 52-Week High Yesterday, September 12",2018-09-13 09:44:00-04:00,NSTG,neutral
921587.0,"Stocks Which Set New 52-Week High Yesterday, September 11th",2018-09-12 12:17:00-04:00,NSTG,neutral
921588.0,48 Biggest Movers From Yesterday,2018-09-12 05:20:00-04:00,NSTG,neutral
921589.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-09-11 12:31:00-04:00,NSTG,neutral
921590.0,"Stocks Which Set New 52-Week High Friday, September 7th",2018-09-10 16:36:00-04:00,NSTG,neutral
921591.0,"NanoString Technologies Raises FY18 Adj. EPS Guidance From $(2.90)-$(2.60) To $(2.70)-$(2.50) vs $(2.72) Est., Raises FY18 Sales Guidance From $100M-$105M To $104M-$106M vs $103.85M Est.",2018-08-07 16:24:00-04:00,NSTG,neutral
921592.0,"NanoString Technologies Q2 EPS $(0.80) Misses $(0.71) Estimate, Sales $25M Beat $24.99M Estimate",2018-08-07 16:22:00-04:00,NSTG,negative
921593.0,42 Stocks Moving In Wednesday's Mid-Day Session,2018-07-18 12:45:00-04:00,NSTG,neutral
921594.0,38 Biggest Movers From Yesterday,2018-07-18 05:47:00-04:00,NSTG,neutral
921595.0,NanoString Reports Commencement Of $50M Common Stock Offering,2018-07-16 16:21:00-04:00,NSTG,neutral
921596.0,UPDATE: NanoString Highlights Several Reasons Q2 Prelim. Sales Were Above Prior Guidance,2018-07-16 16:18:00-04:00,NSTG,neutral
921597.0,"UPDATE: NanoString Raises Q2 Product, Service Sales Guidance From $18.5M-$19.5M To $20.4M vs $25M Estimate",2018-07-16 16:16:00-04:00,NSTG,neutral
921598.0,NanoString Raises Q2 Outlook,2018-07-16 16:16:00-04:00,NSTG,neutral
921599.0,NanoString Shares Up 1%; Co. Earlier Announced Formation Of Research Collaboration With National Cancer Institute,2018-06-04 10:11:00-04:00,NSTG,negative
921600.0,38 Biggest Movers From Yesterday,2018-05-23 04:56:00-04:00,NSTG,neutral
921601.0,NanoString Technologies Sees FY2018 EPS $(2.90)-(2.60) vs $(2.78) Est; Sees Sales $100.0M-105.0M vs $103.31M Est,2018-05-08 16:54:00-04:00,NSTG,neutral
921602.0,"NanoString Technologies Q1 EPS $(0.75) Beats $(0.76) Estimate, Sales $23.085M Beat $21.55M Estimate",2018-05-08 16:54:00-04:00,NSTG,neutral
921603.0,"NanoString Sees FY18 GAAP EPS $(2.90)-$(2.60) vs $(2.45) Est., Sales $100M-$105M vs $109.9M Est.",2018-03-07 16:02:00-05:00,NSTG,neutral
921604.0,"NanoString Technologies Reports Q4 EPS $(0.34) vs $(0.42) Est., Sales $35.2M vs $31.3M Est.",2018-03-07 16:01:00-05:00,NSTG,neutral
921605.0,"NanoString Reports Largest, Most Comprehensive Study Of Prosigna Breast Cancer Assay To Date Published In JCO",2018-02-05 16:04:00-05:00,NSTG,negative
921606.0,NanoString Names Thomas Bailey CFO,2018-01-16 09:01:00-05:00,NSTG,neutral
921607.0,"NanoString Technologies Earlier Reported Prelim FY17 Sales $113M-$115 vs $112.05M Est. and Prior Guidance Of $109M-$112M, Sees Q4 Product and Service Sales $21M",2018-01-08 09:59:00-05:00,NSTG,neutral
921608.0,"NanoString, RikenGenesis Report Partnership to Commercialize nCounter-Based Diagnostic Assays in Japan",2018-01-04 06:02:00-05:00,NSTG,neutral
921609.0,NanoString Technologies Highlights Four Abstracts To Be Presented At ASH,2017-12-07 16:19:00-05:00,NSTG,neutral
921610.0,NanoString Highlights Record Number of nCounter-Based Research Abstracts at SITC 2017,2017-11-09 06:15:00-05:00,NSTG,positive
921611.0,NanoString CFO James Johnson To Resign,2017-11-08 17:29:00-05:00,NSTG,negative
921612.0,55 Biggest Movers From Friday,2017-11-06 05:58:00-05:00,NSTG,neutral
921613.0,48 Stocks Moving In Friday's Mid-Day Session,2017-11-03 12:30:00-04:00,NSTG,neutral
921614.0,"NanoString Technologies Lowers FY17 Sales From $114-$118M To $109-$112M, Increased EPS From $(2.20)-$(2.03) To $(1.99)-$(1.86)",2017-11-02 16:22:00-04:00,NSTG,positive
921615.0,"NanoString Technologies Reports Q3 EPS $(0.45) vs $(0.57) Est., Sales $27.01M vs $26.7M Est.",2017-11-02 16:21:00-04:00,NSTG,neutral
921616.0,Mid-Afternoon Market Update: Crude Oil Down 2%; Infinity Pharmaceuticals Shares Spike Higher,2017-10-12 14:30:00-04:00,NSTG,negative
921617.0,33 Stocks Moving In Thursday's Mid-Day Session,2017-10-12 12:40:00-04:00,NSTG,neutral
921618.0,Mid-Day Market Update: J.Jill Tumbles Following Weak Q3 Outlook; Ardelyx Shares Surge,2017-10-12 12:22:00-04:00,NSTG,negative
921619.0,Mid-Morning Market Update: Markets Edge Lower; JPMorgan Profit Beats Estimates,2017-10-12 10:14:00-04:00,NSTG,positive
921620.0,"Benzinga's Top Upgrades, Downgrades For October 12, 2017",2017-10-12 09:14:00-04:00,NSTG,positive
921621.0,Janney Capital Downgrades NanoString Technologies to Neutral,2017-10-12 08:53:00-04:00,NSTG,neutral
921622.0,Cowen & Co. Downgrades NanoString Technologies to Market Perform,2017-10-12 08:13:00-04:00,NSTG,neutral
921623.0,"7 Stocks To Watch For October 12, 2017",2017-10-12 04:58:00-04:00,NSTG,neutral
921624.0,9 Stocks Moving In Wednesday's After-Hours Session,2017-10-11 17:33:00-04:00,NSTG,neutral
921625.0,UPDATE: Nanostring Cuts Product & Service Revenue Outlook For Q3 From $19.5M-$21.5M to $16.9M,2017-10-11 16:03:00-04:00,NSTG,negative
921626.0,NanoString Reports Prelim. Q3 Sales $25.9M-$26.9M vs $27.68M Est.,2017-10-11 16:02:00-04:00,NSTG,neutral
921627.0,NanoString Technologies Announces Anthem Issues Positive Coverage Decision for Prosigna Breast Cancer Assay,2017-09-05 06:12:00-04:00,NSTG,negative
921628.0,Watch These 5 Huge Call Purchases In Wednesday Trade,2017-08-09 04:20:00-04:00,NSTG,positive
921629.0,NanoString and Lam Research Announce Strategic Development Collaboration,2017-08-08 16:25:00-04:00,NSTG,neutral
921630.0,"NanoString Technologies Raises FY17 EPS Outlook From $(2.51)-$(2.69) to $(2.03)-$(2.20) vs $(2.40) Est., Sales From $100M-$105M to $114M-$118M vs $107.17M Est.",2017-08-08 16:24:00-04:00,NSTG,neutral
921631.0,"NanoString Technologies Reports Q2 EPS $(0.20) vs $(0.35) Est., Sales $34.6M vs $32.93M Est.",2017-08-08 16:22:00-04:00,NSTG,neutral
921632.0,NanoString Tech Option Alert: Jan 19 $20 Calls at the Ask: 1000 @ $0.85 vs 0 OI; Ref=$15.44,2017-08-08 14:39:00-04:00,NSTG,positive
921633.0,NanoString Technologies Prices 3M Share Offering At $16.75/Share,2017-06-01 09:03:00-04:00,NSTG,positive
921634.0,NanoString Technologies Reports Offering of 2.75M Shares,2017-05-31 16:10:00-04:00,NSTG,positive
921635.0,"NanoString Reports Q1 EPS $(0.87) In-line With Est., Sales $18.1M vs $17.06M Est.",2017-05-04 16:58:00-04:00,NSTG,neutral
921636.0,18 Biggest Mid-Day Losers For Thursday,2017-04-20 13:12:00-04:00,NSTG,negative
921637.0,Mid-Morning Market Update: Markets Edge Higher; Verizon Profit Misses Expectations,2017-04-20 10:03:00-04:00,NSTG,positive
921638.0,"Benzinga's Top Upgrades, Downgrades For April 20, 2017",2017-04-20 09:30:00-04:00,NSTG,positive
921639.0,The Market In 5 Minutes,2017-04-20 09:20:00-04:00,NSTG,neutral
921640.0,Morgan Stanley Downgrades NanoString Technologies to Equal-Weight,2017-04-20 06:27:00-04:00,NSTG,neutral
921641.0,NanoString Reports Humana Issued Positive Coverage on Decision for Co.s' Prosigna Breast Cancer Assay,2017-01-31 16:01:00-05:00,NSTG,negative
921642.0,Mid-Afternoon Market Update: Crude Oil Down Over 2%; Pacific Continental Shares Climb On Merger News,2017-01-10 15:28:00-05:00,NSTG,negative
921643.0,15 Biggest Mid-Day Losers For Tuesday,2017-01-10 13:24:00-05:00,NSTG,negative
921644.0,Mid-Day Market Update: Dow Gains Over 50 Points; hhgregg Shares Plunge,2017-01-10 12:05:00-05:00,NSTG,positive
921645.0,"JP Morgan Healthcare Conf. Continues Today; Presenters Include Cooper Companies, Mckesson, Dexcom, CVS, Bristol-Myers, & NanoString",2017-01-10 08:07:00-05:00,NSTG,positive
921646.0,NanoString Technologies Sees FY2016 Sales $85.50M-87.0M vs $90.60M Est,2017-01-10 06:11:00-05:00,NSTG,neutral
921647.0,Nanostring Technologies Sees Q4 2016 Revenue of $24.2M-$25.7M vs $29.07M Est; FY 2016 Revenue of $85.5M-$87M vs $90.59M Est,2017-01-10 05:07:00-05:00,NSTG,neutral
921648.0,NanoString Says Prosigna Outperformed Competitive Treatments,2016-12-12 06:02:00-05:00,NSTG,positive
921649.0,NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies,2016-12-05 17:26:00-05:00,NSTG,neutral
921650.0,"NanoString Sees FY16 Rev. $89-$93M vs. Est. $90M, EPS $(2.30)-$(2.15) vs. Est. $(2.25)",2016-11-02 16:37:00-04:00,NSTG,neutral
921651.0,"NanoString Technologies Reports Q3 EPS $(0.51) vs. Est. $(0.52), Rev. $23.9M vs. Est. $23.46M",2016-11-02 16:36:00-04:00,NSTG,neutral
921652.0,NanoString Technologies Presents Update on Hyb & Seq Next-Generation Sequencing Chemistry at ASHG Annual Meeting,2016-10-19 06:05:00-04:00,NSTG,neutral
921653.0,"25 Stocks Which Rallied Four Days, Then Sold Off Yesterday",2016-09-22 09:47:00-04:00,NSTG,neutral
921654.0,"After-Hours Gainers Aug. 3, '16: OCUL Up 22%, SQ 14.9%, CBMX 13.5%, AXGN 10%, AVID 8.7%, PODD 8.6%, NSTG 8.3%, JACK 8%, EXEL 7.7%",2016-08-03 19:10:00-04:00,NSTG,positive
921655.0,"NanoString Raises FY16 Rev. From $86-$90M To $89-$93M, EPS Loss Down From $(2.45)-$(2.30) To $(2.30)-$(2.15)",2016-08-03 16:13:00-04:00,NSTG,negative
921656.0,"NanoString Reports Q2 EPS $(0.55) vs. Est. $(0.66), Rev. $22.6M vs. Est. $19.6M",2016-08-03 16:12:00-04:00,NSTG,neutral
921657.0,"NanoString Raises FY16 Guidance Rev $89M-$93M vs $87.54M Est, Loss/Share -$2.15-$2.30 vs -$2.42 Est",2016-08-03 16:03:00-04:00,NSTG,neutral
921658.0,"NanoString Reports Q2 Loss -$.55 vs Est Loss $0.66, Rev $22.6M vs $19.62M Est",2016-08-03 16:01:00-04:00,NSTG,negative
921659.0,James Tananbaum Reports 5.9% Stake in Nanostring Technologies in 13G,2016-07-18 16:33:00-04:00,NSTG,neutral
921660.0,"NanoString Reports Q1 EPS $(0.74) vs $(0.69) Est., Sales $14.7M vs $14.9M Est.",2016-05-05 16:01:00-04:00,NSTG,neutral
921661.0,"NanoString Reports Collaboration Deal with HalioDx for Joint Development, Commercialization of Novel Gene Expression Assays in Immuno-oncology",2016-04-11 08:03:00-04:00,NSTG,positive
921662.0,Benzinga's Top Initiations,2016-03-16 09:26:00-04:00,NSTG,positive
921663.0,Janney Capital Initiates Coverage on NanoString Technologies at Buy,2016-03-16 06:51:00-04:00,NSTG,neutral
921664.0,Janney Capital Initiates Coverage on NanoString Technologies at Buy,2016-03-15 17:15:00-04:00,NSTG,neutral
921665.0,"NanoString Sees FY16 EPS $(2.45)-$(2.30) vs $(2.35) Est., Sales $86M-$90M vs $81.6M Est.",2016-02-29 16:09:00-05:00,NSTG,neutral
921666.0,"NanoString Technologies Reports Q4 EPS $(0.44) vs $(0.54) Est., Sales $22.3M vs $21.1M Est.",2016-02-29 16:08:00-05:00,NSTG,neutral
921667.0,Nanostring Technologies Sees Q4 2015 Revenue $21.1M-$22.1M vs $20.99M Est; Sees  FY 2015 Revenue $61.5M-$62.5M vs $61.33M Est,2016-01-10 18:39:00-05:00,NSTG,neutral
921668.0,"NanoString Reports Collaboration Deal with Medivation, Astellas for Development of Novel Companion Diagnostic Test",2016-01-07 07:07:00-05:00,NSTG,positive
921669.0,NanoString Technologies Expands 3D Biology Portfolio With the Commercial Launch of Seven New nCounter PanCancer Profiles to Deeply Probe Cancer Biology,2015-11-05 08:42:00-05:00,NSTG,negative
921670.0,"NanoString Sees FY15 Sales $60M-$63M vs $60.6M Est., Adjusts Operating Loss from $41M-$47M to $40M-$44M",2015-11-02 16:04:00-05:00,NSTG,negative
921671.0,"NanoString Reports Q3 Sales $15.7M vs $15.4M Est., Loss of $0.49/Share vs Loss of $0.50/Share Est.",2015-11-02 16:03:00-05:00,NSTG,negative
921672.0,NanoString Technologies Gets Favorable Final Local Coverage Determination by Palmetto GBA for Its Prosigna Breast Cancer Assay,2015-08-13 16:05:00-04:00,NSTG,positive
921673.0,"NanoString Technologies Names Alessandra Cesano, M.D., Ph.D. as Chief Medical Officer",2015-07-08 16:06:00-04:00,NSTG,neutral
921674.0,NanoSting Tech Appoints Chief Medical Officer,2015-07-08 16:05:00-04:00,NSTG,neutral
921675.0,NanoString Technologies Announces Publication of Clinical Study Demonstrating the Ability of Its Prosigna Breast Cancer Assay to Predict Response to Chemotherapy,2015-07-07 16:06:00-04:00,NSTG,negative
921676.0,NanoString Reports Results from Three Significant New Prosigna Studies at ASCO: Shown to Predict Response to Chemotherapy,2015-06-01 07:32:00-04:00,NSTG,positive
921677.0,Cadian Capital Increases Stake In From 6.32% To 6.7% NanoString Technology,2015-05-26 16:52:00-04:00,NSTG,neutral
921678.0,8-K from NanoString Shows Registration to Offer Up to $40M in Common Shares,2015-05-12 16:39:00-04:00,NSTG,positive
921679.0,"Nanostring Technologies Reports Q1 Loss of $0.81/Share vs Loss of $0.58/Share Est., Sales $11.6M vs $12.1M Est.",2015-05-06 16:58:00-04:00,NSTG,negative
921680.0,"Morgan Stanley Reiterates Overweight, Raises PT On NanoString Technologies On Increased Visibility",2015-03-24 08:23:00-04:00,NSTG,negative
921681.0,"BTIG Research Initiates Coverage on NanoString Technologies at Buy, Announces $16.00 PT",2015-03-17 04:57:00-04:00,NSTG,neutral
921682.0,NanoString Technologies Raises FY2014 Sales Guidance from $46.0M-48.0M to $47.0M-48.0M vs $46.90M Est,2015-01-08 16:10:00-05:00,NSTG,neutral
921683.0,NanoString Technologies Sees Q4 Sales $15.0M-16.0M vs $15.0M Est,2015-01-08 16:10:00-05:00,NSTG,neutral
921684.0,"8-K from NanoString Technologies Shows Co. to Lease ~21.5K Sq. Ft. in New Building in Seattle, Leave to Begin Apr. 1, 2016",2014-12-24 08:06:00-05:00,NSTG,negative
921685.0,NanoString Technologies Highlights Important Results From Prosigna Decision Impact Study,2014-12-15 16:07:00-05:00,NSTG,positive
921686.0,"NanoString Offers Update on Prosigna FDA Labeling, Will Provide Greater Insight Into Probability of Breast Cancer Reccurence",2014-12-08 16:07:00-05:00,NSTG,negative
921687.0,NanoString Technologies Reports Q3 EPS of $(0.54) vs $(0.56) Est; Revenue of $12.30M vs $11.84M Est,2014-11-04 16:04:00-05:00,NSTG,neutral
921688.0,NanoString Technologies Files for Up to $100M Mixed Shelf,2014-08-29 06:13:00-04:00,NSTG,neutral
921689.0,NanoString Technologies Reports Q2 EPS of $(0.58) vs $(0.65) Est,2014-08-05 16:04:00-04:00,NSTG,neutral
921690.0,Form 8-K from Nanostring Shows Reaffirmed FY14 Sales Guidance,2014-06-03 16:43:00-04:00,NSTG,neutral
921691.0,"NanoString Announces Deal with Celgene Related to Development of Revlimid, Will Get Upfront Payment of $5.75M, Eligible for Up to $45M",2014-06-03 16:32:00-04:00,NSTG,neutral
921692.0,NanoString Technologies Reports Q1 EPS of $(0.68) vs $(0.76) Est; Revenue of $8.75M vs $8.37M Est,2014-05-07 16:31:00-04:00,NSTG,neutral
921693.0,NanoString Technologies Receives Canadian Market Approval for its Prosigna Breast Cancer Prognostic Gene Signature Assay ,2014-05-06 16:50:00-04:00,NSTG,negative
921694.0,Nanostring Technologies Reported Q4 Adj. Loss of $0.51/Share,2014-02-26 16:42:00-05:00,NSTG,negative
921695.0,NanoString Technologies Reports Q4 EPS of $(0.60) vs $(0.71) Est; Revenue of $10.10M vs $9.74M Est,2014-02-26 16:08:00-05:00,NSTG,neutral
921696.0,NanoString Announces Study Confirms Ability of Prosigna Assay to Assess Risk of Late Distant Recurrence in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer,2014-02-12 07:36:00-05:00,NSTG,negative
921697.0,Study Confirms Ability of the Prosigna Assay to Assess Risk of Late Distant Recurrence in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer,2014-02-12 07:32:00-05:00,NSTG,negative
921698.0,NanoString Technologies Launches $55M Follow-On Offering,2014-01-21 16:10:00-05:00,NSTG,neutral
921699.0,NanoString Technologies Files Registration Statement With SEC for $55M Offering,2014-01-13 08:55:00-05:00,NSTG,neutral
921700.0,"NanoString Technologies Sees Q4 Sales $10.10M vs $9.60M Est, Sees Higher Oper. Loss vs Year Ago",2014-01-13 07:33:00-05:00,NSTG,negative
921701.0,"UPDATE: Morgan Stanley Downgrades NanoString Tech, Changes PT to NA",2014-01-06 10:47:00-05:00,NSTG,neutral
921702.0,"Morgan Stanley Downgrades NanoString Technologies to Equal-weight, Removes $14.00 PT",2014-01-06 06:50:00-05:00,NSTG,neutral
921703.0,Benzinga's Volume Movers,2013-12-11 10:25:00-05:00,NSTG,neutral
921704.0,Morning Market Movers ,2013-12-11 09:56:00-05:00,NSTG,neutral
921705.0,Baird Upgrades NanoString Technologies to Outperform,2013-12-11 08:46:00-05:00,NSTG,neutral
921706.0,NanoString Technologies Announces Adoption of Prosigna Breast Cancer Assay by Leading US Clinical Laboratories and Cancer Centers,2013-12-11 08:38:00-05:00,NSTG,negative
921707.0,NanoString Technologies Reports Q3 EPS of $(0.44) vs $(0.67) Est; Revenue of $8.39M vs $7.67M Est,2013-11-05 16:27:00-05:00,NSTG,neutral
921708.0,Morning Market Movers ,2013-09-10 10:19:00-04:00,NSTG,neutral
921709.0,NanoString Technologies Reports Q2 Revenue of $7.22M vs $6.80M Est,2013-08-06 16:43:00-04:00,NSTG,neutral
921710.0,UPDATE: J.P. Morgan Initiates NanoString Technologies at Overweight on Ability to Leverage Trends,2013-07-22 09:20:00-04:00,NSTG,negative
921711.0,UPDATE: Morgan Stanley Initiates NanoString Technologies at Overweight on Attractive Growth Story,2013-07-22 09:06:00-04:00,NSTG,positive
921712.0,"Leerink Swann Initiates Coverage on NanoString Technologies at Outperform, Announces $15.00 PT",2013-07-22 08:58:00-04:00,NSTG,neutral
921713.0,Benzinga's Top Initiations,2013-07-22 07:33:00-04:00,NSTG,positive
921714.0,"JP Morgan Initiates Coverage on NanoString Technologies at Overweight, Announces $14.00 PT",2013-07-22 07:29:00-04:00,NSTG,neutral
921715.0,"Morgan Stanley Initiates Coverage on NanoString Technologies at Overweight, Announces $14.00 PT",2013-07-22 07:21:00-04:00,NSTG,negative
921716.0,Nanostring Tech IPO Opens at $9.90 After Pricing at $10/Share,2013-06-26 10:26:00-04:00,NSTG,neutral
921717.0,"IPO for Nanostring to Open for Quote at 10:05AM EDT, to Open for Trade at 10:20AM",2013-06-26 08:43:00-04:00,NSTG,neutral
921718.0,NanoString Technologies Prices 5.4M Share IPO at $10.00/Share,2013-06-25 19:21:00-04:00,NSTG,positive
921719.0,"NanoString Technologies Files $86.25M IPO, Plans to List on NASDAQ",2013-05-20 13:56:00-04:00,NSTG,neutral
